Aligned Genetics's latest marketcap:
As of 04/30/2026, Aligned Genetics's market capitalization has reached $41.05 M. According to our data, Aligned Genetics is the 32721th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 41.05 M |
| Revenue (ttm) | 10.84 M |
| Net Income (ttm) | 1.97 M |
| Shares Out | 14.06 M |
| EPS (ttm) | 0.14 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/15/2026 |
Aligned Genetics's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/02/2026 | ₩48.78 B | $32.23 M | -10.34% | n/a |
| 12/30/2025 | ₩54.41 B | $36.97 M | 25.08% | 31373 |
| 12/30/2024 | ₩43.5 B | $29.14 M | -24.94% | 31664 |
| 12/28/2023 | ₩57.95 B | $44.62 M | 7.04% | 28530 |
| 12/29/2022 | ₩54.14 B | $42.77 M | -12.14% | 27933 |
| 12/30/2021 | ₩61.61 B | $51.76 M | -13.43% | 27328 |
| 12/30/2020 | ₩71.18 B | $0 | 46.13% | 23126 |
| 12/30/2019 | ₩48.71 B | $41.89 M | 3.44% | 22860 |
| 12/28/2018 | ₩47.09 B | $41.91 M | 5.22% | 21925 |
| 12/28/2017 | ₩44.75 B | $41.62 M | -26.3% | 22461 |
Company Profile
About Aligned Genetics, Inc.
Aligned Genetics, Inc. is a global provider of innovative solutions in cellular imaging and biomolecular analysis. The company specializes in delivering cutting-edge technologies to support research and diagnostics.
Product Offerings
- Genescale: Molecular diagnostic solutions designed for rapid and accurate results.
- Logos Biosystems: Advanced imaging and analysis tools for scientific research.
Company Background
Originally founded as Logos Biosystems, Inc. in 2008, the company rebranded to Aligned Genetics, Inc. in September 2020. Headquartered in Anyang-Si, South Korea, the company continues to drive innovation in life sciences.
Frequently Asked Questions
-
What is Aligned Genetics's (KOSDAQ-238120) current market cap?As of 04/30/2026, Aligned Genetics (including the parent company, if applicable) has an estimated market capitalization of $41.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Aligned Genetics (KOSDAQ-238120) rank globally by market cap?Aligned Genetics global market capitalization ranking is approximately 32721 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.